Adrenal Insufficiency as a Result of Ritonavir and Exogenous Steroid Exposure: Report of 6 Cases and Recommendation for Management. |
|
Clinician and patient recognition of anogenital herpes disease in HIV positive men who have sex with men. |
|
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects |
|
A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population |
|
Current status and prospects for development of an HSV vaccine |
|
Cytomegalovirus shedding from breastmilk and mucosal sites in healthy postpartum women: A pilot study |
|
Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes |
|
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial |
|
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses |
|
The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps. |
|
Helicase-primase inhibitor pritelivir for HSV-2 infection |
|
Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review |
|
Herpes simplex virus viremia during primary genital infection, 2007: |
|
High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial |
|
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial |
|
Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents |
|
HSV-2: in pursuit of a vaccine |
|
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial |
|
Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo |
|
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection |
|
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda |
|
Management of Acute Myeloid Leukemia in the Intensive Care Setting. |
|
Model-based estimation of superinfection prevalence from limited datasets. |
|
Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions |
|
Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial |
|
Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa |
|
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition |
|
Proliferative laryngitis with airway obstruction in an adult: Consider herpes. |
|
Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies |
|
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials |
|
T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences. |
|
Tissue-Resident-Memory CD8<sup>+</sup> T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes |
|
Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety |
|
Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling |
|
Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus |
|
性感染症に対する新たなワクチンへの将来的展望 |
|